Supplement, Drug Co-Packaging Potential Could Be Clipped In FDA Proposed Rule
This article was originally published in The Rose Sheet
Executive Summary
Innovus Pharmaceuticals is among the firms offering supplements and OTC drugs sold together, an option CRN encourages FDA to allow. FDA will determine on a case-by-case basis whether co-packaged OTCs and supplements already available are in violation of a proposed rule on drug co-packaging.